dr. hurvitz on the impact of biosimilars
Published 5 years ago • 111 plays • Length 1:38Download video MP4
Download video MP3
Similar videos
-
1:19
dr. hurvitz on the potential global impact of biosimilars in breast cancer
-
0:58
dr. hurvitz on the clinical use of biosimilars in oncology
-
1:11
dr. hurvitz on importance of biosimilars in her2 breast cancer
-
1:55
dr. hurvitz on the fda approval process for biosimilars
-
1:46
dr. hurvitz on biosimilars in breast cancer
-
0:44
dr. hamilton on the impact of biosimilars in oncology
-
5:09
the challenges in manufacturing biologics
-
3:33
biosimilars: manufacturing and inherent variation
-
6:07
manufacturing of biologics
-
1:02
dr jeremy schafer discusses the importance of immunogenicity of biosimilars
-
1:39
dr. hurvitz on the lack of predictive biomarkers in her2 breast cancer
-
2:52
what's health canada saying about biosimilars?
-
7:22
an overview of biosimilarity
-
53:46
biosimilars - impact for patients
-
16:47
what is needed and what is the role of biosimilars?
-
4:12
the basics of biosimilars
-
2:28
what are biologic and biosimilar drugs?
-
1:13
dr. hurvitz on using adcs in her2 breast cancer
-
35:31
understanding biosimilars: how the availability of biosimilars will impact clinical practice
-
9:26
the future direction of biosimilars
-
5:58
the availability of multiple biosimilars for 1 biologic
-
38:35
biosimilars 101